Patent: 10,085,955
✉ Email this page to a colleague
Summary for Patent: 10,085,955
Title: | Methods and compositions for treatment of demyelinating diseases |
Abstract: | Disclosed herein are new oral pharmaceutical compositions of SAMDC inhibitors, polyamine analogs, and polyamine biosynthesis inhibitors, and their application for the treatment of conditions including demyelinating diseases, autoimmune disorders affecting the nervous system, and other neurodegenerative conditions. |
Inventor(s): | Blitzer; Jeremy (San Francisco, CA), McKearn; John (Saint Louis, MO) |
Assignee: | Pathologica LLC (San Francisco, CA) |
Application Number: | 14/759,599 |
Patent Claims: | see list of patent claims |
Details for Patent 10,085,955
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Bayer Healthcare Pharmaceuticals Inc. | BETASERON | interferon beta-1b | For Injection | 103471 | 07/23/1993 | ⤷ Try a Trial | 2033-01-08 |
Biogen Inc. | AVONEX | interferon beta-1a | For Injection | 103628 | 05/17/1996 | ⤷ Try a Trial | 2033-01-08 |
Biogen Inc. | AVONEX | interferon beta-1a | Injection | 103628 | 05/28/2003 | ⤷ Try a Trial | 2033-01-08 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |